Stock screener

OABI

Conviction 100HealthcareScan · Mon, Aug 10, 2026
OABI$3.39+9.90%
ResistanceSupportVol 14
63 bars
Vol MA14 855.96K
May 11May 28Jun 16Jul 6Jul 23Aug 10
OmniAb, Inc.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.omniab.com
Price3.39
Change+9.90%
Gap+1.95%
Rel volume10.09×
Avg volume721.9K
Avg $ vol1.96M
SMA 202.17
SMA 502.29
SMA 2001.91
Price vs 50+47.75%
Price vs 200+77.61%
MA stackbullish
50/200 cross
Supertrendup · 2.52
RSI (14)84
MACD hist0.14
MACD crossbull · 3d
Stoch %K / %D97 / 95
ADX (14)27
+DI / −DI49 / 8
RSI divergence
MACD divergenceBullish
ATR %+6.19%
ADR %7.31%
52w high3.39
52w low1.36
From 52w high+0.00%
Above 52w low+148.90%
New 52w highYes
SqueezeOff
Bollinger width67.32%
%B1.33
Donchian pos96.74%
Donchian high3.44
Donchian low1.90
AVWAP (52w high)3.27
vs AVWAP high+3.46%
AVWAP (52w low)2.02
vs AVWAP low+67.61%
OBV trendUp
Chaikin MF (20)0.44
Today vs 20d10.09×
Avg vol (14d)855.96K
Avg vol (20d)721.9K
Avg $ vol (20d)1.96M
Market cap492.15M
RS 3m (vs SPY)+103.83%
RS 6m (vs SPY)+72.55%
RS line new highYes
Trend template8/8
Technical rank96.8
1 week+72.70%
1 month+47.82%
3 months+103.92%
6 months+99.12%
1 year+80.05%
YTD+80.05%
P/E-7.60
P/B1.89
P/S26.37
P/FCF-13.29
EPS-0.5700
Div yield
ROE-24.89%
ROA-22.32%
Debt/Eq
Current4.80
EV/EBITDA-9.91
Gross margin
Net margin-347.04%
Rev growth-29.27%
EPS growth-4.43%
Price target
Target upside
Analyst rating
Institutional
Ent. value467.81M
Revenue13.41M
Net income-5.86M
Gross profit
Free cash flow-37.02M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out144.97M
Employees89
ListedTue, Nov 1, 2022
Free float73.91M
Float %51.3%
Short interest5.88M
Days to cover10.3d
Short volume35.7%
Squeeze score56 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank96.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance2.59
Support1.93
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OABI

All disclosures →
No recent disclosed trades by Congress in OABI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OABI · 7 buys · 3 sells

InsiderSideShares
Crouse Steven C.
Director · Restricted Stock Units · 2026-06-17
Exercise20K
Crouse Steven C.
Director · Restricted Stock Units · 2026-06-17
Grant20K
Crouse Steven C.
Director · Stock Option (right to buy) · 2026-06-17
Grant40K
Love Steven
Director · Common Stock · 2026-06-17
Exercise20K
Bertozzi Carolyn R
Director · Common Stock · 2026-06-17
Exercise20K
Bertozzi Carolyn R
Director · Restricted Stock Units · 2026-06-17
Exercise20K
Bertozzi Carolyn R
Director · Restricted Stock Units · 2026-06-17
Grant20K
Bertozzi Carolyn R
Director · Stock Option (right to buy) · 2026-06-17
Grant40K
Cochran Jennifer R.
Director · Common Stock · 2026-06-17
Exercise20K
Cochran Jennifer R.
Director · Restricted Stock Units · 2026-06-17
Exercise20K

SEC filings

EDGAR filings in OABI · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.